Clinical Trials Directory

Trials / Completed

CompletedNCT06523075

Host Dysregulation-Driven Sepsis Prediction Model

Construction and Validation of a Sepsis Prediction Model Based on Dysregulation of Host Response

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The aim of this study is to identify risk factors associated with sepsis and to construct a predictive model for sepsis. This will provide an objective theoretical and empirical foundation for the diagnosis, assessment, and management of sepsis in our country.The primary questions addressed are: What are the risk factors for the development of sepsis? How do we improve the prognosis of sepsis?

Conditions

Interventions

TypeNameDescription
OTHERTumor Necrosis FactorThis study is a retrospective observational study, with Tumor Necrosis Factor being one of the exposure factors under investigation.
OTHERInterleukin-1βThis study is a retrospective observational study, with Interleukin-1β being one of the exposure factors under investigation.
OTHERInterleukin-12This study is a retrospective observational study, with Interleukin-12 being one of the exposure factors under investigation.
OTHERInterleukin-18This study is a retrospective observational study, with Interleukin-18 being one of the exposure factors under investigation.
OTHERComplement C3This study is a retrospective observational study, with Complement C3 being one of the exposure factors under investigation.
OTHERComplement C5This study is a retrospective observational study, with Complement C5 being one of the exposure factors under investigation.

Timeline

Start date
2024-09-01
Primary completion
2024-10-13
Completion
2024-10-17
First posted
2024-07-26
Last updated
2024-10-31

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06523075. Inclusion in this directory is not an endorsement.